These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8640783)

  • 1. Definition and refinement of a region of loss of heterozygosity at 11q23.3-q24.3 in epithelial ovarian cancer associated with poor prognosis.
    Gabra H; Watson JE; Taylor KJ; Mackay J; Leonard RC; Steel CM; Porteous DJ; Smyth JF
    Cancer Res; 1996 Mar; 56(5):950-4. PubMed ID: 8640783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a region of frequent loss of heterozygosity at 11q24 in colorectal cancer.
    Connolly KC; Gabra H; Millwater CJ; Taylor KJ; Rabiasz GJ; Watson JE; Smyth JF; Wyllie AH; Jodrell DI
    Cancer Res; 1999 Jun; 59(12):2806-9. PubMed ID: 10383136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome 11q22.3-q25 LOH in ovarian cancer: association with a more aggressive disease course and involved subregions.
    Launonen V; Stenbäck F; Puistola U; Bloigu R; Huusko P; Kytölä S; Kauppila A; Winqvist R
    Gynecol Oncol; 1998 Nov; 71(2):299-304. PubMed ID: 9826475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refinement of the LOH region 1 at 11q23.1 deleted in human breast carcinomas and sublocalization of 11 expressed sequence tags within the refined region.
    di Iasio MG; Calin G; Tibiletti MG; Vorechovsky I; Benediktsson KP; Taramelli R; Barbanti-Brodano G; Negrini M
    Oncogene; 1999 Feb; 18(8):1635-8. PubMed ID: 10102634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refinement of two chromosome 11q regions of loss of heterozygosity in ovarian cancer.
    Davis M; Hitchcock A; Foulkes WD; Campbell IG
    Cancer Res; 1996 Feb; 56(4):741-4. PubMed ID: 8631007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent deletions within FRA7G at 7q31.2 in invasive epithelial ovarian cancer.
    Huang H; Reed CP; Mordi A; Lomberk G; Wang L; Shridhar V; Hartmann L; Jenkins R; Smith DI
    Genes Chromosomes Cancer; 1999 Jan; 24(1):48-55. PubMed ID: 9892108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity in human ovarian cancer on chromosome 19q.
    Bicher A; Ault K; Kimmelman A; Gershenson D; Reed E; Liang B
    Gynecol Oncol; 1997 Jul; 66(1):36-40. PubMed ID: 9234918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas.
    Choi C; Cho S; Horikawa I; Berchuck A; Wang N; Cedrone E; Jhung SW; Lee JB; Kerr J; Chenevix-Trench G; Kim S; Barrett JC; Koi M
    Genes Chromosomes Cancer; 1997 Nov; 20(3):234-42. PubMed ID: 9365830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity at 11q22 correlates with low progesterone receptor content in epithelial ovarian cancer.
    Gabra H; Langdon SP; Watson JE; Hawkins RA; Cohen BB; Taylor L; Mackay J; Steel CM; Leonard RC; Smyth JF
    Clin Cancer Res; 1995 Sep; 1(9):945-53. PubMed ID: 9816065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel 4 cM minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinomas.
    Colitti CV; Rodabaugh KJ; Welch WR; Berkowitz RS; Mok SC
    Oncogene; 1998 Jan; 16(4):555-9. PubMed ID: 9484846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detailed deletion mapping at chromosome 11q23 in colorectal carcinoma.
    Lee AS; Seo YC; Chang A; Tohari S; Eu KW; Seow-Choen F; McGee JO
    Br J Cancer; 2000 Sep; 83(6):750-5. PubMed ID: 10952779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity of chromosome 17 in human borderline and invasive epithelial ovarian tumors.
    Wertheim I; Tangir J; Muto MG; Welch WR; Berkowitz RS; Chen WY; Mok SC
    Oncogene; 1996 May; 12(10):2147-53. PubMed ID: 8668340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3.
    Negrini M; Rasio D; Hampton GM; Sabbioni S; Rattan S; Carter SL; Rosenberg AL; Schwartz GF; Shiloh Y; Cavenee WK
    Cancer Res; 1995 Jul; 55(14):3003-7. PubMed ID: 7606718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel 4-cM minimally deleted region on chromosome 11p15.1 associated with high grade nonmucinous epithelial ovarian carcinomas.
    Lu KH; Weitzel JN; Kodali S; Welch WR; Berkowitz RS; Mok SC
    Cancer Res; 1997 Feb; 57(3):387-90. PubMed ID: 9012461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers.
    Dion F; Mes-Masson AM; Seymour RJ; Provencher D; Tonin PN
    Oncogene; 2000 Mar; 19(11):1466-72. PubMed ID: 10723138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refined mapping of two regions of loss of heterozygosity on chromosome band 11q23 in lung cancer.
    Wang SS; Virmani A; Gazdar AF; Minna JD; Evans GA
    Genes Chromosomes Cancer; 1999 Jun; 25(2):154-9. PubMed ID: 10337999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity at chromosome 9q22-31 is a frequent and early event in ovarian tumors.
    Byrom J; Mudaliar V; Redman CW; Jones P; Strange RC; Hoban PR
    Int J Oncol; 2004 May; 24(5):1271-7. PubMed ID: 15067351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of chromosome 3p deletions in human epithelial ovarian tumors.
    Lounis H; Mes-Masson AM; Dion F; Bradley WE; Seymour RJ; Provencher D; Tonin PN
    Oncogene; 1998 Nov; 17(18):2359-65. PubMed ID: 9811467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
    Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity and transcriptome analyses of a 1.2 Mb candidate ovarian cancer tumor suppressor locus region at 17q25.1-q25.2.
    Presneau N; Dewar K; Forgetta V; Provencher D; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2005 Jul; 43(3):141-54. PubMed ID: 15937959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.